Fundz

Who to call at Corcept, and when

Fundz watches for the moments Corcept starts buying, and tells you who to reach.

  • An alert the day Corcept raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Corcept, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

LaunchCorcept Therapeutics Announces Phase 2 Study Results of Dazucorilant for ALS Patients

Dec 11, 2024
Menlo ParkBiotechnologyHealth CareMedicalTherapeuticsBiotechnology Research

Product Description

Corcept Therapeutics has announced the results of the DAZALS study, a Phase 2 trial evaluating the effectiveness of its selective cortisol modulator, dazucorilant, in patients with ALS. The trial did not meet its primary endpoint, but will continue with an open-label long-term extension study.

Company Information

Company

Corcept

Location

Menlo Park, California, United States

About

Leading the field in the discovery of drugs that modulate the effects of cortisol. The adverse effects of excess cortisol have been Corcept’s focus since the company’s inception. Abnormal levels and release of cortisol play a role in a variety of metabolic, oncological, and psychiatric diseases, and we are currently studying a new generation of compounds that may mitigate the effects of excess cortisol.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Corcept ships something new, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Monica hidden

hidden
Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Corcept's next move

Learn about Strategic plan

Product Launch Insights

What this usually means
Market expansion signals
New product launches often coincide with market expansion initiatives

Corcept shipped something new. Fundz reads product launches, trademark filings and hiring together.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.